Sign in

You're signed outSign in or to get full access.

Didier Wimmers

Executive Vice President of Research & Development at AEHR TEST SYSTEMSAEHR TEST SYSTEMS
Executive

About Didier Wimmers

Didier Wimmers (age 63) serves as Executive Vice President of Research & Development at Aehr Test Systems, having joined on March 3, 2025; he holds a Master’s degree in Electrical Engineering from INSA Lyon (France) and has extensive leadership experience across semiconductor test and semiconductor companies . He replaced the prior R&D head following a leadership transition and is part of the executive team responsible for product development execution and innovation focus . Company performance context since FY2023 is shown below (TSR and net income); these are company-level indicators overlapping his tenure, not individual attribution .

MetricFY 2023FY 2024FY 2025
TSR value of initial $100 investment$394 $137 $114
Net Income (Loss) ($000)$14,557 $33,156 $(3,910)

Past Roles

OrganizationRoleYearsStrategic impact
Schlumberger Automated Test Equipment (Schlumberger Ltd.)Executive engineering managementLed worldwide product development teams with focus on customer needs, innovation, quality, on‑time delivery
NPTest (later acquired by Credence Systems)Executive engineering managementBuilt world-class engineering teams in semiconductor test
Credence Systems (later acquired by Xcerra)Executive engineering managementAs above
FormFactorExecutive engineering managementAs above
Altera (acquired by Intel)Executive engineering managementAs above
Thin Film Electronics ASAExecutive engineering managementAs above
Advantest America (Advantest Corp.)Executive engineering managementAs above

External Roles

  • No public-company board roles or committee positions for Mr. Wimmers were disclosed in the 2025 proxy statement .

Fixed Compensation

  • Mr. Wimmers was not a Named Executive Officer (NEO) in FY2025; the NEOs were CEO (Erickson), CFO (Siu), and COO (Engineer). Individual salary/bonus detail for Mr. Wimmers was not provided in the 2025 proxy .

Performance Compensation

Aehr’s executive compensation program uses cash bonus and equity (options and RSUs, including performance-based RSUs) under the 2023 Equity Incentive Plan; awards are subject to clawback, and repricing is prohibited without shareholder approval .

Metric/ConditionTypeVesting/Payout StructureNotes
Time-based stock optionsOptions1/48 monthly; fully vested at 4 years, service-basedPlan terms; exercise price ≥ FMV at grant
Time-based RSUsRSUs1/16 every three months; fully vested at 4 years, service-basedStandard RSU schedule
FY2025 performance RSUsRSUs (performance + time)25% vests based on FY2025 financial goals; then 1/16 quarterly over next 3 yearsEarnout can be 0–200%; FY2025 component earned at 200% based on actual performance
Cumulative revenue performance RSURSUs (performance)100% vests upon achieving cumulative revenue target through May 31, 2026As of May 30, 2025, performance not yet met
Clawback policyRecovery3-year lookback on incentive comp after material restatementApplies to Section 16 officers; effective Aug 14, 2023
Prohibition on repricingGovernanceNo option/SAR repricing without shareholder approvalExcept for corporate transactions

Note: The proxy does not provide individual award amounts or metric weightings for Mr. Wimmers; details above reflect plan mechanics and selected outcomes applicable to executives in aggregate .

Equity Ownership & Alignment

  • Policy prohibits short sales, hedging, derivatives, margin purchases, and pledging of company stock by covered individuals (including named executive officers); insider trading policy is on file with the 10‑K. This mitigates misalignment from pledging or hedging .
DateFilingTransactionShares (A/D)PriceBeneficially Owned AfterNotes
2025-06-03 (filed 06-12-2025)Form 3Initial statement13,601Includes unvested RSUs (footnote)
2025-09-03 (filed 09-03-2025)Form 4Withholding for taxes on RSU vest (Code F)(308)$24.5213,293Not a sale; withholding only
2025-10-01 (filed 10-01-2025)Form 4ESPP purchase+1,628$6.672514,921Purchase under IRC §423 tax-conditioned plan (exempt from §16 short-swing)
  • Ownership as % of outstanding shares (approximate): 14,921 / 29,968,988 ≈ 0.05%; outstanding shares as of August 28, 2025 were 29,968,988 .

  • Options: None reported on the above Section 16 filings; holdings are primarily common stock and RSUs .

Employment Terms

AreaTermsApplicability
Offer/severance agreementThe 2025 proxy discloses new severance agreements for CEO (Erickson), CFO (Siu), and COO (Engineer) with specified cash, equity acceleration, and healthcare benefits upon qualifying terminations (enhanced during CIC window). Mr. Wimmers is not named among these agreements in the proxyErickson/Siu/Engineer only
Change-in-control (equity plan)If awards are not assumed/substituted in a CIC, time-based awards fully vest; performance goals deemed at 100% for awards with performance criteria; similar treatment disclosed for non-employee directors2023 Equity Plan terms
Clawback policyRecovery of erroneously awarded incentive-based compensation for three fiscal years preceding a material restatement; applies to Section 16 officersCompany-wide policy
Hedging/pledgingProhibited (short sales, options/derivatives on company stock, hedging, purchase on margin, or pledging)Applies to covered individuals (includes named executive officers)

Investment Implications

  • Alignment/pressure: Filings show no discretionary open-market selling; one tax withholding event on RSU vest and a subsequent ESPP purchase at $6.67, which reduces near-term selling pressure and signals engagement with long-term equity ownership .
  • Retention and incentives: While individual salary/bonus specifics are not disclosed for Mr. Wimmers, the standard Aehr package (time-based and performance RSUs with four-year vesting, clawback, and anti-hedging/pledging) supports retention and alignment; FY2025 performance RSUs across executives earned at the 200% maximum underscores a high-performance payout environment but is not individually attributed to Mr. Wimmers .
  • Contract protection: Unlike CEO/CFO/COO, the proxy does not list Mr. Wimmers among executives with the 2024 severance/CIC agreements, suggesting comparatively less disclosed cash protection in a transition scenario; equity acceleration still governed by the 2023 Plan if not assumed in a CIC .
  • Execution risk/track record: His background across leading ATE and semiconductor firms (Schlumberger ATE, Credence, FormFactor, Altera, Advantest) indicates deep domain expertise to drive R&D execution; company TSR and profitability volatility across FY2023–FY2025 provides a mixed backdrop for value creation post‑hire, warranting monitoring of product milestones and revenue-linked performance awards .

Citations:

Form 3: https://www.sec.gov/Archives/edgar/data/1040470/000159396825000753/0001593968-25-000753.txt
Form 4 (09/03/2025): https://www.sec.gov/Archives/edgar/data/1040470/000159396825000992/0001593968-25-000992.txt and https://www.sec.gov/Archives/edgar/data/1040470/000159396825000992/xslF345X05/primary_01.xml
Form 4 (10/01/2025): https://www.sec.gov/Archives/edgar/data/1040470/000104047025000019/xslF345X05/primary_01.xml